IG Therapeutics is an European pharmaceutical company dedicated to the healthcare sector, acting through processes of investment, licensing, registration and distribution. The company has a high-skilled team that works every day on new concepts, new developments, new products, new partnerships and new ways to reach the patient. Our presence covers mature and emerging regions, focusing primarily in Europe, having offices in Birmingham and Lisbon.
Our strength is based on the continuous tracking of the needs and trends within scientific and technological areas, transforming the challenges into solutions and solutions into reality.
Company Details
- Employees
- 6
- Founded
- -
- Address
- Birmingham, Birmingham,birmingham B2 5jp,united Kingdom
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- ig-therapeutics.com
- Keywords
- Pharmaceuticals, Medical Devices, Biotechnology, Research, Licensing, Investment, Healthcare, International Business, Market Access, Consumer Healthcare, Health Technologies, mHealth, eHealth, Digital Health.
- HQ
- Birmingham, Birmingham
Ig Therapeutics Questions
Ig Therapeutics's website is ig-therapeutics.com
Ig Therapeutics's LinkedIn profile is https://uk.linkedin.com/company/igtherapeutics
Ig Therapeutics has
6 employees.
View email and phone details for 6
employees at Ig Therapeutics.
Ig Therapeutics's industry is
Pharmaceutical Manufacturing
Ig Therapeutics's top competitors are
V2m Pharma,
Domantis,
Emprofac,
Concept,
Pharma Bavaria International Gmbh,
Cold Chain Iq,
Autolus Therapeutics,
Zs,
Phagecon - Serviços E Consultoria Farmacêutica, Lda.,
Project Sentinel.
Ig Therapeutics's categories are Pharmaceutical Manufacturing
Ig Therapeutics's founding year is 2016
